ArticleFrontiers in neurology2022
Validation of the Chinese Version of the Stigma Scale of Epilepsy.
Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 17 citations in OpenAlex.
- Validation of the Mental Health First Aid Knowledge Questionnaire for use among Chinese non-mental health nurses.BMC psychology · 2025Article
- Development and psychometric evaluation of an integrative Manual Muscle Test for patients with post-stroke hemiplegia.European journal of physical and rehabilitation medicine · 2025Observational
- Psychometric evaluation of the Chinese version of the Educational Leadership Scale for Nursing Students: a quantitative cross-sectional design.Frontiers in psychology · 2025Article
- Article
- A Chinese version of the infertility self-efficacy scale: Reliability and validity assessment.Heliyon · 2024Article
- Translation and validation of the Breastfeeding Motivation Scale in China.International breastfeeding journal · 2024Article
- Psychometric assessment of the Chinese adaptation of the patient participation scale targeting inpatients: a validation research.Frontiers in psychology · 2024Article
- Epilepsy in Asian countries.Acta epileptologica · 2023Review
- Translation and validation of the Chinese version of the acceptance and action questionnaire for cancer in patients with advanced lung cancer.Asia-Pacific journal of oncology nursing · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study was carried out to test the validity and reliability of the Chinese version of the Stigma Scale of Epilepsy (SSE), with aim to better understand the public stigmatizing attitudes of epilepsy in China and help elucidate stigma determinants for interventions.
methodsThe SSE was translated into Simplified Chinese Mandarin. In this study, most of the participants were enrolled
resultsThe Cronbach's alpha is 0.936 for the overall scale, and the CVI value is greater than 0.78. The exploratory factor analysis (EFA) extracted SSE six factors: the fear of seizure attacks (factor 1), sympathy for patients with epilepsy (PWEs) (factor 2); difficulties faced by PWEs (factor 3); speculation on PWEs' feeling (factor 4); discrimination against PWEs (factor 5); and knowledge about epilepsy (factor 6). The item 13 was proven to be problematic and has been eliminated. The confirmatory factor analysis (CFA) ensured the great construct validity (χ
conclusionsThe Chinese version of the SSE scale was a valid and reliable tool to measure epilepsy-associated stigma in the Chinese society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.